Using the Cnga3−/− mouse model of achromatopsia (Biel et al, 1999), we also report a first validation of AAV2.GL in a proof‐of‐concept study for restoring cone photoreceptor function after intravitreal gene supplementation therapy. This evidence concerns the gene CNGA3 and achromatopsia.